0000929638-24-002743.txt : 20240807 0000929638-24-002743.hdr.sgml : 20240807 20240807154752 ACCESSION NUMBER: 0000929638-24-002743 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dukes Iain D. CENTRAL INDEX KEY: 0001681955 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 241183349 MAIL ADDRESS: STREET 1: 112 W. 34TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Traws Pharma, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 PENNS TRAIL CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3680 MAIL ADDRESS: STREET 1: 12 PENNS TRAIL CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: Onconova Therapeutics, Inc. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 4/A 1 form4.xml X0508 4/A 2024-04-01 2024-04-03 0001130598 Traws Pharma, Inc. TRAW 0001681955 Dukes Iain D. 12 PENNS TRAIL NEWTOWN PA 18940 true true Executive Chairman false Common Stock 2024-04-01 4 A 0 67500 A 134187 D On April 3, 2024, the reporting person filed a Form 4 that inadvertently reported the number of shares of common stock (the "Common Stock") of Traws Pharma, Inc. (f/k/a Onconova Therapeutics, Inc.) underlying a grant of restricted stock units as 67,550 instead of 67,500. Nevertheless, the number of shares of Common Stock beneficially owned following the reported transaction was correctly reported in the original Form 4 as 134,187. Represents an award of restricted stock units that will vest in four equal annual installments beginning April 1, 2025. Each restricted stock unit will convert into shares of Common Stock on a one-for-one basis. /s/ Iain Dukes 2024-08-07